Effects of brief, clustered versus dispersed hypoxic episodes on systemic and ocular growth factors in a rat model of oxygen-induced retinopathy

Pediatric Research

Volumn 64, Issue 1, 2008, Pages 50-55

  Coleman, Rebecca J ^a,b   Beharry, Kay D A ^a   Brock, Romy S ^b   Abad Santos, Patricia ^b   Abad Santos, Matthew ^b   Modanlou, Houchang D ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MILLER CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; OXYGEN; SOMATOMEDIN C; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY HEIGHT; BODY WEIGHT; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; HYPEROXIA; HYPOXIA; NEOVASCULARIZATION (PATHOLOGY); NEWBORN; NONHUMAN; OXYGEN INDUCED RETINOPATHY; OXYGEN THERAPY; PRIORITY JOURNAL; PUP (RODENT); RAT; RETINA; RETINA HEMORRHAGE; RETINOPATHY; RETROLENTAL FIBROPLASIA; SYSTEMATIC REVIEW; ANIMAL; ANOXIA; BLOOD; COMPARATIVE STUDY; DISEASE MODEL; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; METABOLISM; PATHOLOGY; RETINA NEOVASCULARIZATION; SPRAGUE DAWLEY RAT;

ANIMALS; ANOXIA; BODY WEIGHT; DISEASE MODELS, ANIMAL; GESTATIONAL AGE; GROWTH HORMONE; HUMANS; HYPEROXIA; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR I; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL NEOVASCULARIZATION; RETINOPATHY OF PREMATURITY; SEVERITY OF ILLNESS INDEX; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 49849083854     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e31817307ac     Document Type: Article

References (26)

1. Hameed B, Shyamanur K, Kotecha S, Manktelow BN, Woodruff G, Draper ES 2004 Trends in the incidence of severe retinopathy of prematurity in a geographically defined population over a 10-year period. Pediatrics 113:1653-1657
2. Gibson DL, Sheps SB, Uh SH, Schechter MT, McCormick AQ 1990 Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic. Pediatrics 86:405-412
3. Chow LC, Wright KW, Sola A CSMC Oxygen Administration Study Group 2003 Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics 111:339-345
4. York JR, Landers S, Kirby RS, Arbogast PG, Penn JS 2004 Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants. J Perinatol 24:82-87
5. Penn JS, Tolman BL, Henry MM 1994 Oxygen-induced retinopathy in the rat: relationship of retinal nonperfusion to subsequent neovascularization. Invest Ophthalmol Vis Sci 35:3429-3435
6. Penn JS, Henry MM, Tolman BL 1994 Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Pediatr Res 36:724-731
7. McColm JR, Geisen P, Hartnett ME 2004 VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. Mol Vis 10:512-520
8. Penn JS, McCollum GW, Barnett JM, Werdich XQ, Koepke KA, Rajaratnam VS 2006 Angiostatic effect of penetrating ocular injury: role of pigment epithelium- derived factor. Invest Ophthalmol Vis Sci 47:405-414
9. Werdich XQ, McCollum GW, Rajaratnam VS, Penn JS 2004 Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy. Exp Eye Res 79:623-630
10. Holmes JM, Duffner LA 1996 The effect of postnatal growth retardation on abnormal neovascularization in the oxygen-exposed neonatal rat. Curr Eye Res 15:403-409
11. Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chan-Ling T, Keshet E 1995 Development of retinal vasculature is mediated by hypoxia-induced vascular endo- thelial growth factor (VEGF) expression by neuroglia. J Neurosci 15:4738-4747
12. Ferrara N 2000 Vascular endothelial growth factor and the regulation of angiogen- esis. Recent Prog Horm Res 55:15-35
13. Cunningham S, McColm JR, Wade J, Sedowofia K, Mcintosh N, Fleck B 2000 A novel model of retinopathy of prematurity simulating preterm oxygen variability in the rat. Invest Ophthalmol Vis Sci 41:4275-4280
14. Aiello LP, Northup JM, Keyt BA, Takagi H, Iwamoto MA 1995 Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 113:1538-1544
15. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LE 1995 Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 92:10457-10461
16. Gille H, Kowalski J, Li B, LeCouter J, Moffat B, Zioncheck TF, Pelletier N, Ferrara N 2001 Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endo- thelial growth factor mutants. J Biol Chem 276:3222-3230
17. Ferrara N, Davis-Smyth T 1997 The biology of vascular endothelial growth factor. Endocr Rev 18:4-25
18. Rota R, Riccioni T, Zaccarini M, Lamartina S, Gallo AD, Fusco A, Kovesdi I, Balestrazzi E, Abeni DC, Ali RR, Capogrossi MC 2004 Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer. J Gene Med 6:9921002
19. Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard AL, Liu JL, Albertsson-Wikland K, Carlsson B, Niklasson A, Sjodell L, LeRoith D, Senger DR, Smith LE 2001 Low IGF-1 suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA 98:58045808
20. Hellstrom A, Engstrom E, Hard AL, Albertsson-Wikland K, Carlsson B, Niklasson A, Lofqvist C, Svensson E, Holm S, Ewald U, Holmstrom G, Smith LE 2003 Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 112:10161020
21. Smith LE, Shen W, Perruzzi C, Soker S, Kinose F, Xu X, Robinson G, Driver S, Bischoff J, Zhang B, Schaeffer JM, Senger DR 1999 Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 5:1390-1395
22. Modanlou HD, Gharraee Z, Hasan J, Waltzman J, Nageotte S, Beharry KD 2006 Ontogeny of VEGF, IGF-1 and GH in neonatal rat serum, vitreous fluid, and retina from birth to weaning. Invest Ophthalmol Vis Sci 47:738-744
23. Smith LE, Kopchick JJ, Chen W, Knapp J, Kinose F, Daley D, Foley E, Smith RG, Schaeffer JM 1997 Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276:1706-1709
24. Hikino S, Ihara K, Yamamoto J, Takahata Y, Nakayama H, Kinukawa N, Narazaki Y, Hara T 2001 Physical growth and retinopathy in preterm infants: involvement of IGF-I and GH. Pediatr Res 50:732-736
25. Radetti G, Bozzola M, Paganini C, Valentini R, Gentili L, Tettoni K, Tato L 1997 Growth hormone bioactivity and levels of growth hormone, growth hormone- binding protein, insulin-like growth factor I, and insulin-like growth factor-binding proteins in premature and full-term newborns during the first month of life. Arch Pediatr Adolesc Med 151:170-175
26. STOP-ROP Multicenter Study Group 2000 Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 105:295-310